Healthcare Recommendations
New healthcare recommendations for Joubert Syndrome were released in 2019.
- You can purchase online access to the medical journal article here.
- For a brief summary of the latest findings, check out Dr. Dan Doherty’s video about the recommendations or check out the abstract below.
- Interested in getting more info about the recommendations – for you and your doctor? Email info@jsrdf.org.
“Joubert syndrome (JS) is a recessive neurodevelopmental disorder defined by a characteristic cerebellar and brainstem malformation recognizable on axial brain magnetic resonance imaging as the “Molar Tooth Sign”. Although defined by the neurological features, JS is associated with clinical features affecting many other organ systems, particularly progressive involvement of the retina, kidney, and liver. JS is a rare condition; therefore, many affected individuals may not have easy access to subspecialty providers familiar with JS (e.g., geneticists, neurologists, developmental pediatricians, ophthalmologists, nephrologists, hepatologists, psychiatrists, therapists, and educators). Expert recommendations can enable practitioners of all types to provide quality care to individuals with JS and know when to refer for subspecialty care. This need will only increase as precision treatments targeting specific genetic causes of JS emerge. The goal of these recommendations is to provide a resource for general practitioners, subspecialists, and families to maximize the health of individuals with JS throughout the lifespan.”
Ruxandra Bachmann‐Gagescu
Jennifer C. Dempsey
Sara Bulgheroni
Maida L. Chen
Stefano D’ArrigoIan A. Glass
Theo Heller
Elise Héon
Friedhelm Hildebrandt
Nirmal Joshi
Dana Knutzen
Hester Y. Kroes
Stephen H. Mack
Sara Nuovo
Melissa A. Parisi
Joseph Snow
Angela C. Summers
Jordan M. Symons
Wadih M. Zein
Eugen Boltshauser
John A. Sayer
Meral Gunay‐Aygun
Enza Maria Valente
Dan Doherty